Our Results Speak
$2B+
Top line growth for one client in technology in life sciences
$150B+
Total addressable markets identified and pursued
20+
Industries served across four continents
25+
Years of strategy and execution work
$50B+
M&A deals supported and closed across Tech, CPG and more.
8
Core capabilities across strategy and execution
THE VAXA DIFFERENCE
Future First
Always
Most strategy starts from where you are and optimises forward. We start from where the growth landscape could be — and design the path backward to make it real.
It's a different instinct. One we've applied across more than two decades — in boardrooms, in competitive pitches against the world's largest strategy firms, and in the kind of work that doesn't make the case study but changes the company.
"Have patience. The obvious is available to everyone. If you think the answer is coming, ask what you've missed."
— THE VAXA WORK PHILSOSPHY
Wednesday uncertainty before a Friday review is a good sign for us. It means we haven't stopped at the comfortable answer.
We are not hired for the obvious. Clieints want a team with courage to uncover the unobvious and pursue the difficult path—and back it up with rigor.
That is what we create and deliver.
WHO WE SERVE
Growth That
Outlasts the Cycle
Whether you're navigating hyper-growth, the limits of your current model, or the disruption you didn't see coming — we bring the outside-in thinking to unlock what's next.
We've worked with companies like Hewlett-Packard, IBM, Ford, and DuPont at precisely these inflection points — where the comfortable answer is available and the right one is not.
-
Growth and revenue acceleration
-
Channels & go-to-market strategy
-
Susainability integration
-
Organizational design for scale
-
AI & emerging technology strategy
INVESTORS & FOUNDERS
From Capital
to Compounding Value
The gap between a good investment and a great outcome is almost always execution — strategy that wasn't designed for the actual company in its actual context.
We close that gap for PE firms, corporate venturers, and founders who need more than a funding opinion—they need someone who has been inside the problem.
-
PE deal sourcing & portfolio optimisation
-
CVC program design & management
Founders Circle mentorship
Funding & capital raising strategy and closing
Exit strategy & preparation
INSIGHTS
The Thinking That
Drives the Work.
GROWTH STRATEGY
Beyond the Adjacent: Why Horizon-3 Growth Requires a Different Kind of Courage
Most growth strategies optimize the familar. The ones that change companies entirely start somewhere else--at the boundary of what currently seems achievable. The companies that make genuine leaps didn't start from where they were. They started with where the world is going--and built backward from there.
CHANNELS
Mindshare Before Market Share
The question isn't how much your partners sell. it's why they sell what they sell--and how to change that before you invest in programs that won't move the number.
CORPORATE VENTURING
CVC as an Advantage--Not a Portfolio Exercise
Corporate venture capital works when it's built as strategy. Most CVC programs fall short as they arebuilt as fiance. The difference is detectable in the firs conversation.
Stay ahead of what's forming. Subscribe to Vaxa Insights — our look at the critical issues and emerging opportunities facing businesses today.